Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

Detalles Bibliográficos
Autores principales: Souchet, Benoit, Audrain, Mickael, Billoir, Baptiste, Lecanu, Laurent, Tada, Satoru, Braudeau, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879886/
https://www.ncbi.nlm.nih.gov/pubmed/29557364
http://dx.doi.org/10.4103/1673-5374.226389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879886/
https://www.ncbi.nlm.nih.gov/pubmed/29557364
http://dx.doi.org/10.4103/1673-5374.226389

Ejemplares similares